Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more?
- 1 October 2003
- journal article
- case report
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 149 (4), 869-876
- https://doi.org/10.1046/j.1365-2133.2003.05639.x
Abstract
We report three patients with blastic natural killer (NK)‐cell lymphoma of the skin associated with myelodysplastic syndrome (MDS) (two patients) or subacute myelomonocytic leukaemia (one patient). In two patients MDS was diagnosed before skin lesions; the patient with leukaemia initially presented with skin lesions. Our patients had several clinical features in common, namely multiple skin lesions with a bruise‐like appearance, involvement of the oral mucosa, and good general status at presentation but very rapid deterioration in the course of the disease. All patients died of disease 4–14 months after the diagnosis. Histopathologically, there were cutaneous infiltrates of slightly pleomorphic medium‐sized cells expressing CD4, CD56, terminal deoxynucleotidyl transferase (focally) and being negative for surface CD3, cytotoxic molecules, B‐cell‐associated markers and myelomonocytic markers. Erythrocyte extravasation was seen in all patients. T‐cell receptor genes were in germline configuration. MDS was classified as refractory cytopenia with multilineage dysplasia and ring sideroblasts and refractory anaemia with transition to refractory anaemia with excess of blasts. We reviewed similar cases reported in the literature showing coexistence of blastic NK‐cell lymphoma/leukaemia and MDS or myelogenous leukaemia. We conclude that given an overall limited number of reported cases of blastic NK‐cell lymphoma/leukaemia, its association with various myelodysplastic/myeloproliferative disorders seen in a subset of patients (≈ 15–20%) is more than coincidental and may indicate their common origin.Keywords
This publication has 20 references indexed in Scilit:
- `Agranular CD4+ CD56+ Hematodermic Neoplasm' (Blastic NK-Cell Lymphoma) Originates From a Population of CD56+ Precursor Cells Related to Plasmacytoid MonocytesThe American Journal of Surgical Pathology, 2002
- CD56 TdT blastic natural killer cell tumor of the skinCancer, 2002
- Clinical and biologic features of CD4+CD56+ malignanciesBlood, 2002
- A case of lymphoblastoid natural killer (NK)-cell lymphoma: association with the NK-cell receptor complex CD94/NKG2 and TP53 intragenic deletionBritish Journal of Dermatology, 2002
- Angioimmunoblastic Lymphadenopathy (AILD) May Respond to Thalidomide Treatment: Two Case ReportsLeukemia & Lymphoma, 2002
- Identification of a leukemic counterpart of the plasmacytoid dendritic cellsBlood, 2001
- Cutaneous Monomorphous CD4- and CD56-Positive Large-Cell LymphomaDermatology, 2000
- Chronic Myelomonocytic Leukemia Derived from a Possible Common Progenitor of Monocytes and Natural Killer CellsLeukemia & Lymphoma, 2000
- Plasmacytoid monocyte proliferation associated with myeloproliferative disordersCancer, 1992
- Plasmacytoid monocytes (so-called plasmacytoid T cells) in Hodgkin's diseaseThe Journal of Pathology, 1989